Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-027941

President & CEO sold 130,000 shares at an average $84.05 ($10,926,066)

  • President & CEO acquired 130,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-01 Exercise or conversion : show line 1 in the form +43,334 $10.69 $463,240 280,481 D
2018-05-01 Sale : show line 2 in the form −43,334 $83.65 $3,624,889 237,147 D
2018-05-02 Exercise or conversion : show line 3 in the form +43,333 $10.69 $463,230 280,480 D
2018-05-02 Sale : show line 4 in the form −43,333 $85.63 $3,710,605 237,147 D
2018-05-03 Exercise or conversion : show line 5 in the form +43,333 $10.69 $463,230 280,480 D
2018-05-03 Sale : show line 6 in the form −43,333 $82.86 $3,590,572 237,147 D
Open-market sales · 130,000 sh · avg $84.05 · $10,926,066

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-05-01 Exercise or conversion : show line 7 in the form Stock Option −43,334 256,666 D
2018-05-02 Exercise or conversion : show line 8 in the form Stock Option −43,333 213,333 D
2018-05-03 Exercise or conversion : show line 9 in the form Stock Option −43,333 170,000 D
Loading xslF345X03/doc4.xml…